Can a common drug and vitamin e shield lungs from radiation harm?
NCT ID NCT06634056
First seen Jan 20, 2026 · Last updated May 15, 2026 · Updated 24 times
Summary
This study tests whether adding pentoxifylline and vitamin E to standard cancer treatment can prevent lung injury (pneumonitis) in 150 adults with stage III non-small cell lung cancer. Participants will receive the drugs alongside chemoradiation and immunotherapy. The goal is to reduce side effects and improve quality of life without affecting cancer control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Health Network - Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2C1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.